BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32621695)

  • 1. Review of the use of gentian violet in dermatology practice.
    Pona A; Quan EY; Cline A; Feldman SR
    Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentian violet: a 19th century drug re-emerges in the 21st century.
    Maley AM; Arbiser JL
    Exp Dermatol; 2013 Dec; 22(12):775-80. PubMed ID: 24118276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical gentian violet in dermatology.
    Bunker CB
    J Am Acad Dermatol; 2009 Feb; 60(2):347-8. PubMed ID: 19150283
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical gentian violet for cutaneous infection and nasal carriage with MRSA.
    Okano M; Noguchi S; Tabata K; Matsumoto Y
    Int J Dermatol; 2000 Dec; 39(12):942-4. PubMed ID: 11168669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema.
    Brockow K; Grabenhorst P; Abeck D; Traupe B; Ring J; Hoppe U; Wolf F
    Dermatology; 1999; 199(3):231-6. PubMed ID: 10592403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet.
    Wright SC; Maree JE; Sibanyoni M
    Phytomedicine; 2009 Mar; 16(2-3):118-24. PubMed ID: 19109001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of gentian violet and brilliant green against some microorganisms associated with skin infections.
    Bakker P; Van Doorne H; Gooskens V; Wieringa NF
    Int J Dermatol; 1992 Mar; 31(3):210-3. PubMed ID: 1568820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of extensive erythema multiforme with topical gentian violet.
    Murthy RK; Van L; Arbiser JL
    Exp Dermatol; 2017 May; 26(5):431-432. PubMed ID: 27376564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentian violet for pyoderma gangrenosum: a retrospective chart review.
    Stiff KM; Glines KR; Muse ME; Cline A; Feldman SR; Jorizzo JL; Huang WW
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
    Mukherjee PK; Chen H; Patton LL; Evans S; Lee A; Kumwenda J; Hakim J; Masheto G; Sawe F; Pho MT; Freedberg KA; Shiboski CH; Ghannoum MA; Salata RA;
    AIDS; 2017 Jan; 31(1):81-88. PubMed ID: 27677161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions.
    Saji M; Taguchi S; Uchiyama K; Osono E; Hayama N; Ohkuni H
    J Hosp Infect; 1995 Nov; 31(3):225-8. PubMed ID: 8586792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing.
    Mak SS; Molassiotis A; Wan WM; Lee IY; Chan ES
    Cancer Nurs; 2000 Jun; 23(3):220-9. PubMed ID: 10851773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lugol's solution and Gentian violet eradicate methicillin-resistant Staphylococcus aureus biofilm in skin wound infections.
    Grønseth T; Ovchinnikov KV; Carlsen H; Benth JŠ; Diep DB; von Unge M; Silvola JT
    Int Wound J; 2023 Jan; 20(1):120-130. PubMed ID: 35633295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RCT on gentian violet versus a hydrogel dressing for radiotherapy-induced moist skin desquamation.
    Gollins S; Gaffney C; Slade S; Swindell R
    J Wound Care; 2008 Jun; 17(6):268-70, 272, 274-5. PubMed ID: 18666721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus.
    Kayama C; Goto Y; Shimoya S; Hasegawa S; Murao S; Nakajo Y; Nibu K
    J Otolaryngol; 2006 Dec; 35(6):384-6. PubMed ID: 17380832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of gentian violet and similar products commonly used to treat pyodermas.
    Berrios RL; Arbiser JL
    Dermatol Clin; 2011 Jan; 29(1):69-73. PubMed ID: 21095530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of diffuse B-cell lymphoma of the leg with intralesional gentian violet.
    Rao S; Morris R; Rice ZP; Arbiser JL
    Exp Dermatol; 2018 Jan; 27(1):93-95. PubMed ID: 28833549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of nonHerlitz junctional epidermolysis bullosa to topical gentian violet.
    Venugopal SS; Intong LR; Cohn HI; Mather-Hillon J; Murrell DF
    Int J Dermatol; 2010 Nov; 49(11):1282-5. PubMed ID: 20964648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of methylene blue and gentian violet dressing for management of chronic wounds with local infection.
    Woo KY; Heil J
    Int Wound J; 2017 Dec; 14(6):1029-1035. PubMed ID: 28508548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis from pyoctanin.
    Schoppelrey HP; Mily H; Agathos M; Breit R
    Contact Dermatitis; 1997 Apr; 36(4):221-4. PubMed ID: 9165207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.